Insights into Company Bills & Payments

Lokesh Machines Ltd

📍 Hyderabad, Telangana, India Active NSE LOKESHMACH CIN L29219TG1983PLC004319 Heavy Engineering & Capital Goods
Search companies

Key Metrics of Lokesh Machines Ltd

Revenue₹209 Cr▼ 8.7% YoYFY 2025-26
EBITDA₹39.3 Cr▲ 31.3% YoY
Net profit₹3.86 Cr▲ 619.4% YoY
Net worth₹228 Cr▲ 7.3% YoY
Competitors10identified

About Lokesh Machines Ltd

Sectors

Heavy Engineering & Capital GoodsMachine Tools & Industrial Machinery

Company details

Registered office
B-29, Eeie, Stage-2, Balanagar,, Hyderabad, In-ts, 500037
Listed
NSE: LOKESHMACH · ₹364.75

Operational Areas of Lokesh Machines Ltd

Heavy Engineering & Capital Goods›Machine Tools & Industrial Machinery

Company summary

Entity details

CINL29219TG1983PLC004319
LEI code335800AK2NCLCLDD9D55
State codeTG
PIN code500037
Current legal nameLOKESH MACHINES LTD
Classification—
Listing statusListed (NSE: LOKESHMACH)
Registration no.004319
Company age—
PAN—
CountryIndia
CityHyderabad
StateTelangana
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code29219
Description of main activityManufacture of machinery and equipment
Description of business activityManufacture of machinery and equipment
SectorHeavy Engineering & Capital Goods · Machine Tools & Industrial Machinery

Share price · NSE: LOKESHMACH

LOKESHMACH on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 26 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 30 Sep 2026 CARE BBB- Stable outlook · Short term A3 · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on record▲ 2 notchessince Jan 2019
Rating actions121 up · 1 down
Liquidity (CARE)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
30 Sep 2026CAREReaffirmed BBB-A3Stable₹208 Cr View
09 Sep 2026CAREReaffirmed BBB-A3Stable₹204 Cr View
29 Aug 2025CAREDowngraded (from BBB) BBB-A3Stable₹204 Cr View
24 Feb 2025CAREReaffirmed BBB—Negative₹217 Cr View
04 Oct 2024CAREUpgraded (from BBB-) BBBA3+Stable₹217 Cr View
05 Jan 2024CAREReaffirmed BBB-A3Positive₹221 Cr View
29 Mar 2023CAREAssigned BBB-A3Stable₹175 Cr View
26 Jul 2022CAREWithdrawn BB+A4+Positive— View
16 Aug 2021CAREReaffirmed (from BB+) BB+A4+Positive₹205 Cr View
13 Oct 2020CAREReaffirmed BB+A4Negative₹190 Cr View
28 Aug 2019CAREReaffirmed (from BB) BB+A4Stable₹164 Cr View
14 Jan 2019CAREReaffirmed (from B-) BBA4Stable₹85.2 Cr View

Credit strengths (CARE, Sep 2026)

+ Comfortable capital structure

The entity's capital structure remained comfortable as on March 31, 2026, marked by an overall gearing ratio of 0.74x (PYE: 0.63x) and a total outside liabilities to tangible net worth (TOL/TNW) ratio of 1.12x (PYE: 0.96x). TNW increased to ₹227.97 crore as on March 31, 2026, from ₹212.36 crore as on March 31, 2025, providing a strong equity base to support the company's operations and future growth. The debt profile primarily comprises external borrowings in the form of working capital faciliti

+ Healthy profitability

Improvement in PBILDT margin despite moderation in TOI reflects the company's shift towards higher -value CNC machines and a greater focus on machine manufacturing, which offers better margins compared to job-work operations. Discontinuation of job - work operations following the OFAC listing also supported margins, as the job -work segment carried relatively lower margins owing to higher overhead and associated costs, while machine manufacturing is comparatively less power and man power

+ Reputed and diversified customer base

With over four decades of industry presence, LML established strong and long -standing relationships with its customers, resulting in repeat business and a stable customer base. The company has established itself as a prominent manufacturer of CNC machines in India and caters to a reputed clientele across industries. LML also has an established export presence, with its products being supplied to markets including Russia, Italy, the US, Bahrain, and Turkey, providing some geographical diversific

+ Extensive industry experience of promoters

LML is promoted by Lokeshwara Rao M, who serves as the Managing Director and has been instrumental in steering the company’s strategic direction and growth. The board is strengthened by Krishnaswamy K, Director, who brings over four decades of extensive industry experience and oversees the company’s overseas operations. Complementing this is Srinivas Mullapudi, Director, with three decades of experience in the sector and significant expertise in managing and expanding the company’s in ternationa

Credit challenges

− Moderate scale of operations

The company reported an 8.57% decline in TOI to ₹208.81 crore in FY26 from ₹228.38 crore in FY25, primarily due to business disruptions following the inclusion of LML in the Specially Designated Nationals and Blocked Persons List by the United State s Department of the Treasury’s OFAC in October 2024. The sanctions disrupted supply of electronic components from a key supplier, adversely affecting production and order execution. The company subsequently arranged alternative sources of supply to m

− Moderate debt coverage indicators

Debt coverage indicators improved marginally in FY26, although they remained at moderate levels. Total debt to gross cash accruals (TD/GCA) ratio improved to 8.14x as on March 31, 2026, from 9.06x as on March 31, 2025, while the PBILDT interest coverage ratio improved to 2.10x in FY26 from 1.88x in FY25. Similarly, the TD/PBILDT ratio moderated to 4.39x in FY26 from 4.68x in FY25. Improvement across coverage indicators was primarily driven by the increase in operating profitability.

− Profitability vulnerable to fluctuation in raw material prices

Raw material consumption constitutes a significant cost component for the company, with steel and aluminium being the primary inputs. Prices of these commodities remained volatile in the last few years. Adverse movement in raw material prices, without a corresponding adjustment in finished goods prices, could impact the company’s profitability. While finished goods prices are generally aligned with raw material prices, order-based nature of operations results in a time lag in passing on cost cha

Could lead to an upgrade

• Steady growth in revenue to over ₹350 crore while maintaining profit before interest, lease rentals, depreciation, and taxati on (PBILDT) margin of ~15% on a sustained basis. • Total debt to PBILDT improving to less than 2.5x, on a sustained basis.

Could lead to a downgrade

• Deterioration in total operating income (TOI) or PBILDT by over 30% y -o-y. • Overall gearing weakening to over 1x. • Significantly elongating operating cycle, impacting company’s

Agency-reported financials (CARE, 30 Sep 2026)

MetricMarch 31, 2025March 31, 2026Q1FY27
Total operating income₹228 Cr₹209 Cr₹55.77 Cr
PBILDT*₹28.56 Cr₹38.54 Cr₹9.92 Cr
Profit after tax (PAT)₹0.54 Cr₹3.86 Cr₹1.01 Cr
Overall gearing (x)0.63×0.74×—
Interest coverage (x)1.88×2.10×2.13×
Revenue growth (YoY)—−8.6%—
PAT margin0.2%1.8%1.8%

Borrowings & rated debt

Rated borrowing limits (latest)₹208 Cr
Peak rated limits₹221 CrJan 2024 · CARE
Limits raised0 times2 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹164 Cr— BBB- (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹44.5 Cr— A3ReaffirmedCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
Bank Guarantee—Withdrawn
BG/LC₹44.5 CrCARE A3
Cash Credit—Withdrawn
Cash Credit₹89.0 CrCARE BBB-; Stable
ILC/FLC—Withdrawn
Letter of credit—Withdrawn
Term Loan—Withdrawn
Term Loan₹75.0 CrCARE BBB-; Stable

Lenders

Fund-based - LTCash CreditIndusInd Bank Ltd.
Fund-based - LTCash CreditPunjab National Bank
Fund-based - LTCash CreditState Bank of India
Fund-based - LTTerm LoanIndusInd Bank Ltd.
Fund-based - LTTerm LoanPunjab National Bank
Fund-based - LTTerm LoanState Bank of India
Non-fund-based - STBG/LCPunjab National Bank
Non-fund-based - STBG/LCState Bank of India

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStretchedAgency: Adequate
DirectionStableAgency outlook: Stable
CARE rating · Sep 2026BBB-2 notches below indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
WithdrawalCARE · 26 Jul 2022 · Withdrawn at company request with lender NOCs
Next action stable or better (model)51%
Information on file89% · missing: Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 50% (At risk of downgrade) · ML model on 6893 rating histories, AUC 0.653
Rated limits₹208 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage2.13×
Limit utilisation89%
Open bank charges0 · —
  • Credit outlook model: 50% chance the next rating action is stable or better
  • Current rating BBB- (investment grade)
  • Interest coverage 2.13×
  • Working-capital limits 89% utilised on average

What happened, step by step

Refinanced bank debt with new funding
  1. Jan 2019 — ₹16.37 cr raised
  2. Jan 2019 — Full repayment of long term debt

“During FY17, there was infusion of Rs. 16.37 crore and during FY18 there has been an infusion of Rs. 4.15 crore. 1 Complete definition of the ratings assigned are available at www.careratings.com and other CARE publications 1 CARE Ratings Limited Press Release Long track record of operations and relationship with key c...”

Capex funded with bank debt
  1. Mar 2023 — Project / plant of ₹55.5 cr
  2. Mar 2023 — Term debt tied up (₹39 cr)

“Ongoing debt funded capex The company has undertaken expansion project in two of its facilities with upgradation and replacement of machineries resulted in increase in installed capacity coupled with backward integration of manufacturing of forgings with t he total project cost of Rs. 55.50 crore.”

Rated limits by facility

Timeline

30 Sep 2026 CARE reaffirmed: BBB- (Stable)Rated limits ₹208.45 cr CARE rationale
30 Sep 2026 New borrowing arranged (term loans)
From the report

The relatively longer manufacturing cycle for higher -value machines results in working capital remaining tied up in WIP for an extended period.

CARE rationale
30 Sep 2026 Average working-capital utilisation 89%
From the report

Average utilisation of working capital limits for 12 months ended June 30, 2026, remained at 89% for fund-based facilities and 62% for non-fund-based facilities.

CARE rationale
30 Sep 2026 Cash & liquid funds ₹0.87 cr
From the report

Unencumbered cash and bank balances stood at ₹0.87 crore as on March 31, 2026.

CARE rationale
09 Sep 2026 CARE reaffirmed: BBB- (Stable)Rated limits ₹204.48 cr CARE rationale
09 Sep 2026 New borrowing arranged (term loans)
From the report

The relatively longer manufacturing cycle for higher -value machines results in working capital remaining tied up in WIP for an extended period.

CARE rationale
09 Sep 2026 Average working-capital utilisation 89%
From the report

The average utilisation of working capital limits in the 12-month period ended June 30, 2026, remained at 89% for fund -based facilities and 62% for non-fund-based facilities.

CARE rationale
09 Sep 2026 Cash & liquid funds ₹0.87 cr
From the report

Unencumbered cash and bank balances stood at ₹0.87 crore as on March 31, 2026.

CARE rationale
29 Aug 2025 CARE downgraded: BBB- (Stable)Rated limits ₹204.48 cr CARE rationale
29 Aug 2025 New borrowing arranged (term loans)
From the report

The debt profile is largely comprised of term loans, including Guaranteed Emergency Credit Line (GECL) facilities availed to support liquidity in the pandemic, and working capital borrowings to fund day-to-day operations.

CARE rationale
29 Aug 2025 Average working-capital utilisation 83.93%
From the report

Average utilisation of working capital limits over the 12 months ended May 2025 was 83.93% for fund-based facilities and 44.19% for non-fund-based facilities.

CARE rationale
29 Aug 2025 Cash & liquid funds ₹20.91 cr
From the report

Net cash flow from operations was positive at ₹20.91 crore in FY25, and unencumbered cash and bank balances stood at ₹0.43 crore as on March 31, 2025.

CARE rationale
24 Feb 2025 CARE reaffirmed: BBB (Negative)Rated limits ₹217.22 cr CARE rationale
24 Feb 2025 Cash & liquid funds ₹20.71 cr
From the report

The company’s cash accruals improved from ₹20.71 crore in FY23 to ₹25.7 crore in FY24.

CARE rationale
24 Feb 2025 Average working-capital utilisation 86%
From the report

The current ratio of the company stood at 1.35x as on March 31, 2024, average utilisation of working capital limits stood at 86%.

CARE rationale
24 Feb 2025 ₹12.34 cr raised through equity
From the report

An equity infusion of ₹12.34 crore has been made in FY25, with additional infusions expected, which will further strengthen the company’s liquidity position in the future.

CARE rationale
04 Oct 2024 CARE upgraded: BBB (Stable)Rated limits ₹217.22 cr CARE rationale
04 Oct 2024 Cash & liquid funds ₹20.71 cr
From the report

The company’s cash accruals improved from ₹20.71 crore in FY23 to ₹25.7 crore in FY24. 1Complete definition of ratings assigned are available at www.careedge.in and other CARE Ratings Limited’s publications. 1 CARE Ratings Ltd.

CARE rationale
04 Oct 2024 Average working-capital utilisation 86%
From the report

The current ratio of the company stood at 1.35x as on March 31, 2024, average utilisation of working capital limits stood at 86%.

CARE rationale
05 Jan 2024 CARE reaffirmed: BBB- (Positive)Rated limits ₹221.21 cr CARE rationale
05 Jan 2024 ₹23 cr raised through equity
From the report

Ratings also favourably factor expected infusion of equity (through preferential allotment) of around Rs 23 crore by Mar 31. 2024 which will strengthen the company’s net-worth base.

CARE rationale
05 Jan 2024 Cash & liquid funds ₹17 cr
From the report

The cash accruals of the company improved from Rs.17 crore in FY22 to Rs.21 crore in FY23.

CARE rationale
05 Jan 2024 Average working-capital utilisation 83%
From the report

The current ratio of the company stood at 1.25x as on March 31, 2023, the average utilisation of working capital limits stood at 83%.

CARE rationale
29 Mar 2023 CARE assigned: BBB- (Stable)Rated limits ₹174.79 cr CARE rationale
29 Mar 2023 Cash & liquid funds ₹12 cr
From the report

The cash accruals of the company improved from Rs.12 crore in FY21 to Rs.16 crore in FY22.

CARE rationale
29 Mar 2023 Capex / project: ₹55.5 cr
From the report

Ongoing debt funded capex The company has undertaken expansion project in two of its facilities with upgradation and replacement of machineries resulted in increase in installed capacity coupled with backward integration of manufacturing of forgings with t he total project cost of Rs. 55.50 crore.

CARE rationale
29 Mar 2023 New borrowing arranged: ₹39 cr (term loans)
From the report

For the said project company has availed the term loans of Rs.39 crore from banks and remaining amount of Rs.16.50 crore funded through internal accruals.

CARE rationale
29 Mar 2023 Average working-capital utilisation 85%
From the report

Liquidity: Adequate The liquidity position of the company remained adequate marked by GCA of Rs.16.56 crore in FY22 against repayment obligation of Rs.6.59 crore The current ratio of the company stood at 1.39x as on March 31, 2022, the average utilisation of working cap ital limits stood at 85% and the company earned net cash flows from operations of Rs.22.86 crore in FY22 to support the liquidity.

CARE rationale
29 Mar 2023 Cash & liquid funds ₹22.86 cr
From the report

Liquidity: Adequate The liquidity position of the company remained adequate marked by GCA of Rs.16.56 crore in FY22 against repayment obligation of Rs.6.59 crore The current ratio of the company stood at 1.39x as on March 31, 2022, the average utilisation of working cap ital limits stood at 85% and the company earned net cash flows from operations of Rs.22.86 crore in FY22 to support the liquidity.

CARE rationale
29 Mar 2023 Debt repayments due: ₹6.59 cr
From the report

Liquidity: Adequate The liquidity position of the company remained adequate marked by GCA of Rs.16.56 crore in FY22 against repayment obligation of Rs.6.59 crore The current ratio of the company stood at 1.39x as on March 31, 2022, the average utilisation of working cap ital limits stood at 85% and the company earned net cash flows from operations of Rs.22.86 crore in FY22 to support the liquidity.

CARE rationale
29 Mar 2023 Debt repayments due: ₹8.39 cr
From the report

The company is expecting a GCA of Rs.21.81 crore in FY23 vis a vis repayment obligation of Rs.8.39 crore.

CARE rationale
26 Jul 2022 CARE withdrawn: BB+ (Positive) CARE rationale
16 Aug 2021 CARE reaffirmed: BB+ (Positive)Rated limits ₹205.38 cr CARE rationale
16 Aug 2021 New borrowing arranged: ₹87 cr (term loans)
From the report

The debt levels increased to about Rs. 87 crore as on March 31, 2021 as company availed COVID loans of Rs. 16 crore. during the year.

CARE rationale
13 Oct 2020 CARE reaffirmed: BB+ (Negative)Rated limits ₹190.34 cr CARE rationale
13 Oct 2020 New borrowing arranged: ₹4.45 cr (term loans)
From the report

Also, the company availed additional COVID relief loan amounting to Rs 4.45 crore in order to meet its short term cash flow mismatches.

CARE rationale
13 Oct 2020 Average working-capital utilisation 96.65%
From the report

The average working capital utilization was high at 96.65% for the past twelve 2 CARE Ratings Limited Press Release months ended June, 2020.

CARE rationale
28 Aug 2019 CARE reaffirmed: BB+ (Stable)Rated limits ₹164.22 cr CARE rationale
28 Aug 2019 Cash & liquid funds ₹1.07 cr
From the report

The cash balance of the company was modest at Rs 1.07 crore as on March 31, 2019.

CARE rationale
14 Jan 2019 CARE reaffirmed: BB (Stable)Rated limits ₹85.19 cr CARE rationale
14 Jan 2019 Full repayment of long term debt
From the report

Overall gearing ratio has improved in the last year on account of repayment of long term debt.

CARE rationale
14 Jan 2019 Cash & liquid funds ₹3.08 cr
From the report

The company had cash and bank balances to the tune of Rs. 3.08 crore (incl. margin money deposits) as on March 31, 2018.

CARE rationale
14 Jan 2019 ₹16.37 cr raised
From the report

During FY17, there was infusion of Rs. 16.37 crore and during FY18 there has been an infusion of Rs. 4.15 crore. 1 Complete definition of the ratings assigned are available at www.careratings.com and other CARE publications 1 CARE Ratings Limited Press Release Long track record of operations and relationship with key clients: LML has long term relationship with Mahindra & Mahindra and Ashok Leyland.

CARE rationale
14 Jan 2019 Average working-capital utilisation 90%
From the report

The average working capital utilization was on higher side of over 90%.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeB-29, EEIE, STAGE-2, BALANAGAR,, HYDERABAD, IN-TS, 500037
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Lokesh Machines Ltd

Competitors10identified
Locations4most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Larsen & Toubro Capital Goods & Power Equipment · Heavy Engineering & Capital Goods larsentoubro.com 1938 Mumbai, India
Thermax Capital Goods & Power Equipment · Heavy Engineering & Capital Goods thermaxglobal.com 1980 Pune, India
Sany Heavy Industry India Private Limited Machine Tools & Industrial Machinery · Construction sanyexcavator.com — Maharashtra, India
Blue Dart Express Outlets operated by Blue Dart Express. bluedart.com 1983 Mumbai, India
H.G. INFRA ENGINEERING LIMITED (PART IX) Machine Tools & Industrial Machinery · Heavy Engineering & Capital Goods — — Jodhpur, Rajasthan, India
Tata Hitachi Construction Machinery Company Machine Tools & Industrial Machinery · Heavy Engineering & Capital Goods tatahitachi.co.in 1961 Bangalore, India
Kirloskar Brothers Capital Goods & Power Equipment · Heavy Engineering & Capital Goods kirloskarpumps.com 1888 Pune, India
Sansera Engineering Limited Machine Tools & Industrial Machinery · Heavy Engineering & Capital Goods sansera.in — Bangalore, Karnataka, India
Action Construction Equipment Limited Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs ace-cranes.com 2009 Palwal, India
AJAX Engineering Part of Fiori Group. ajax-engg.com 1992 Bangalore, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.